Clinical Trial Update: Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating lacidipine in adults with type 2 diabetes and mild-to-moderate essential hypertension in Korea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lacidipine (Lacidipine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2, Essential Hypertension | Phase 4 | Status: COMPLETED